Explore the role of lifestyle, exercise, genetics and biology in the genesis of Alzheimer's and vascular dementia.
Learn how medications may help prevent the downside into dementia if Alzeheimer's disease is diagnosed in the early stage of mild cognitive impairment.
Find out how to be screened to join a cutting edge, a global clinical trial which is seeking treatments for Alzheimer's disease.
The speaker, Cherian Verghese, MD, MRCPsych(UK), is the Principal Investigator at Keystone Clinical Studies, Norristown, PA and Assistant Professor of Psychiatry at Temple University. With a background in academic psychiatric research, he is a Key Opinion Leader in the field of drug development for psychiatric disorders and novel psychiatric medications. Co-Sponsored with Friends Life Care (FLC)
|